Diseño de un proyecto de investigación básico

Nos proponemos que los estudiantes entren en contacto con las actividades de investigación y que, de manera autónoma, aunque guiados por el profesor, encuentren la respuesta a una pregunta mediante el desarrollo del método científico, haciendo uso también de unos procedimientos básicos para la elaboración de un proyecto de investigación.We propose that the students come in contact with the activities of research and that, in an autonomous manner, while guided by the professor, to find the answer to a question through the development of the scientific method, by using a few basic procedures for the preparation of a research project

Dynamic interaction of SARAF with STIM1 and orai1 to modulate store-operated calcium entry

El flujo de Ca2+ por almacenado por canales de Ca2+ es un mecanismo importante para la homeostasis intracelular de Ca2+ y la función celular. Aquí presentamos la evidencia de la interacción dinámica entre el factor regulador asociado SOCE (SARAF), STIM1 y Orai1. La expresión atenuada SARAF y la interacción SOCE STIM1-Orai1 en células expresan endógenamente a STIM1 y Orai1 mientras RNAi está condicionada por silenciamiento de SARAF induciendo efectos opuestos. SARAF menoscaba la asociación entre Orai1 y la activación de Orai1 del pequeño fragmento de STIM1 expresada en la STIM1-L115-401NG deficiente de células. En tratamiento de la celda con agonistas o thapsigargin fisiológico resulta en asociación directa de SARAF con Orai1. La interacción de ESTIMI1 independiente de SARAF con Orai1 conduce a la activación de este canal. Las células expresan endógenamente STIM1 y el agotamiento del almacenado de Orai1, Ca2+ conduce a la disociación de SARAF de STIM1 a los 30 segundos después del tratamiento con thapsigargin, paralelo al aumento de SARAF en la interacción con Orai1, seguido por reinteracción con STIM1 y la disociación desde Orai1. La expresión de SARAF y Orai1 o la supresión de diversos N-terminal de mutantes de Orai1 no altera la interacción de SARAF-Orai1; sin embargo, la expresión de eliminación de C-terminal y los mutantes de Orai1 bloquean la C-terminal de Orai1 y menoscaban la interacción con SARAF. Estas observaciones sugieren que SARAF ejerce un papel positivo inicial en la activación de SOCE seguida por la facilitación del SCDI de Orai1.Ca2+ influx by store-operated Ca2+ channels is a major mechanism for intracellular Ca2+ homeostasis and cellular function. Here we present evidence for the dynamic interaction between the SOCE associated regulatory factor (SARAF), STIM1 and Orai1. SARAF overexpression attenuated SOCE and the STIM1-Orai1 interaction in cells endogenously expressing STIM1 and Orai1 while RNAi-mediated SARAF silencing induced opposite effects. SARAF impaired the association between Orai1 and the Orai1-activating small fragment of STIM1 co-expressed in the STIM1-deficient NG115-401L cells. Cell treatment with thapsigargin or physiological agonists results in direct association of SARAF with Orai1. STIM1-independent interaction of SARAF with Orai1 leads to activation of this channel. In cells endogenously expressing STIM1 and Orai1, Ca2+ store depletion leads to dissociation of SARAF withSTIM1 approximately 30s after treatment with thapsigargin, which paralleled the increase in SARAFOrai1 interaction, followed by reinteraction with STIM1 and dissociation from Orai1. Co-expression of SARAF and either Orai1 or various N-terminal deletion Orai1 mutants did not alter SARAF-Orai1 interaction; however, expression of C-terminal deletion Orai1 mutants or blockade of the C-terminus of Orai1 impair the interaction with SARAF. These observations suggest that SARAF exerts an initial positive role in the activation of SOCE followed by the facilitation of SCDI of Orai1.• Ministerio de Economía y Competitividad. Becas BFU2013-45564-C2-1-P, BFU2013-45564-C2-2-P, BFU2011-24365 and RD12-0043-0016 (RETICEF) • Ministerio de Economía y Competitividad. Programa Juan de la Cierva para José Javier López Barba • Ministerio de Economía y Competitividad. Beca BES-2011-043356 para Letizia Albarrán Alonso • Junta de Extremadura y Fondos FEDERpeerReviewe

EFHB is a novel cytosolic Ca²+ sensor that modulates STIM1-SARAF interaction

FUNDAMENTOS/OBJETIVOS: STIM1 y Orai1 son los componentes clave de la entrada de Ca2+ en la tienda (SOCE). Entre las proteínas que participan en la regulación de la SOCE, la SARAF previene la activación espontánea de la SOCE y modula la función de STIM1. MÉTODOS: Se estimó la movilización de Ca2+ citosólico en células cargadas de fura-2 usando un microscopio invertido de epifluorescencia. La interacción de STIM1 con Orai1, EFHB (miembro de la familia B del dominio de la mano EF, también conocido como CFAP21) y SARAF se detectó mediante inmunoprecipitación seguida de Western blotting utilizando anticuerpos específicos. La participación de EFHB en la translocación de NFAT al núcleo se detectó mediante microscopía confocal. RESULTADOS: Aquí reportamos la identificación del EFHB como un nuevo regulador SOCE. El EFHB interactúa con el STIM1 al agotarse el almacenamiento y se disocia a través de un mecanismo dependiente de Ca2+-. El silenciamiento mediado por el ARNi así como los estudios de sobreexpresión revelaron que el EFHB juega un papel relevante en la interacción de STIM1 y Orai1 al agotarse las reservas, la activación de la translocación de SOCE y NFAT del citosol al núcleo. El silenciamiento de la expresión de la EFHB suprimió la disociación de la SARAF de la STIM1, lo que indica que la EFHB podría desempeñar un papel importante en la interacción dinámica entre ambas proteínas, lo que es pertinente para la activación de los canales de Orai1 al agotarse el almacenamiento de Ca2+ y su posterior modulación mediante la inactivación lenta dependiente del Ca2+. CONCLUSIÓN: Nuestros resultados indican que el EFHB es un nuevo regulador SOCE que modula la interacción STIM1-SARAF.BACKGROUND/AIMS: STIM1 and Orai1 are the key components of store-operated Ca2+ entry (SOCE). Among the proteins involved in the regulation of SOCE, SARAF prevents spontaneous activation of SOCE and modulates STIM1 function. METHODS: Cytosolic Ca2+ mobilization was estimated in fura-2-loaded cells using an epifluorescence inverted microscope. STIM1 interaction with Orai1, EFHB (EF-hand domain family member B, also known as CFAP21) and SARAF was detected by immunoprecipitation followed by Western blotting using specific antibodies. The involvement of EFHB in the translocation of NFAT to the nucleus was detected by confocal microscopy. RESULTS: Here, we report the identification of EFHB as a new SOCE regulator. EFHB interacts with STIM1 upon store depletion and dissociates through a Ca2+- dependent mechanism. RNAi-mediated silencing as well as overexpression studies revealed that EFHB plays a relevant role in the interaction of STIM1 and Orai1 upon store depletion, the activation of SOCE and NFAT translocation from the cytosol to the nucleus. Silencing EFHB expression abolished the dissociation of SARAF from STIM1, which indicates that EFHB might play an important role in the dynamic interaction between both proteins, which is relevant for the activation of Orai1 channels upon Ca2+ store depletion and their subsequent modulation via slow Ca2+-dependent inactivation. CONCLUSION: Our results indicate that EFHB is a new SOCE regulator that modulates STIM1-SARAF interaction.• Ministerio de Economía y Competitividad. Contrato Juan de la Cierva IJCI-2015-25665, para Isaac Jardín Polo • Junta de Extremadura y Fondos FEDER. Contrato IB16046, para José Javier López Barba • Ministerio de Economía y Competitividad. Subvención BFU2016-74932-C2-1-P, para Letizia Albarrán Alonso • Ministerio de Economía y Competitividad. Subvenciones Subvenciones BFU2013-45564-C2-1-P/2-P y BFU2016-74932-C2-1-P/2-P • Junta de Extremadura y Fondos FEDER. Subvenciones IB16046 y GR18061peerReviewe

CIBERER : Spanish national network for research on rare diseases: A highly productive collaborative initiative

Altres ajuts: Instituto de Salud Carlos III (ISCIII); Ministerio de Ciencia e Innovación.CIBER (Center for Biomedical Network Research; Centro de Investigación Biomédica En Red) is a public national consortium created in 2006 under the umbrella of the Spanish National Institute of Health Carlos III (ISCIII). This innovative research structure comprises 11 different specific areas dedicated to the main public health priorities in the National Health System. CIBERER, the thematic area of CIBER focused on rare diseases (RDs) currently consists of 75 research groups belonging to universities, research centers, and hospitals of the entire country. CIBERER's mission is to be a center prioritizing and favoring collaboration and cooperation between biomedical and clinical research groups, with special emphasis on the aspects of genetic, molecular, biochemical, and cellular research of RDs. This research is the basis for providing new tools for the diagnosis and therapy of low-prevalence diseases, in line with the International Rare Diseases Research Consortium (IRDiRC) objectives, thus favoring translational research between the scientific environment of the laboratory and the clinical setting of health centers. In this article, we intend to review CIBERER's 15-year journey and summarize the main results obtained in terms of internationalization, scientific production, contributions toward the discovery of new therapies and novel genes associated to diseases, cooperation with patients' associations and many other topics related to RD research

RICORS2040 : The need for collaborative research in chronic kidney disease

Chronic kidney disease (CKD) is a silent and poorly known killer. The current concept of CKD is relatively young and uptake by the public, physicians and health authorities is not widespread. Physicians still confuse CKD with chronic kidney insufficiency or failure. For the wider public and health authorities, CKD evokes kidney replacement therapy (KRT). In Spain, the prevalence of KRT is 0.13%. Thus health authorities may consider CKD a non-issue: very few persons eventually need KRT and, for those in whom kidneys fail, the problem is 'solved' by dialysis or kidney transplantation. However, KRT is the tip of the iceberg in the burden of CKD. The main burden of CKD is accelerated ageing and premature death. The cut-off points for kidney function and kidney damage indexes that define CKD also mark an increased risk for all-cause premature death. CKD is the most prevalent risk factor for lethal coronavirus disease 2019 (COVID-19) and the factor that most increases the risk of death in COVID-19, after old age. Men and women undergoing KRT still have an annual mortality that is 10- to 100-fold higher than similar-age peers, and life expectancy is shortened by ~40 years for young persons on dialysis and by 15 years for young persons with a functioning kidney graft. CKD is expected to become the fifth greatest global cause of death by 2040 and the second greatest cause of death in Spain before the end of the century, a time when one in four Spaniards will have CKD. However, by 2022, CKD will become the only top-15 global predicted cause of death that is not supported by a dedicated well-funded Centres for Biomedical Research (CIBER) network structure in Spain. Realizing the underestimation of the CKD burden of disease by health authorities, the Decade of the Kidney initiative for 2020-2030 was launched by the American Association of Kidney Patients and the European Kidney Health Alliance. Leading Spanish kidney researchers grouped in the kidney collaborative research network Red de Investigación Renal have now applied for the Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS) call for collaborative research in Spain with the support of the Spanish Society of Nephrology, Federación Nacional de Asociaciones para la Lucha Contra las Enfermedades del Riñón and ONT: RICORS2040 aims to prevent the dire predictions for the global 2040 burden of CKD from becoming true

Nurses' perceptions of aids and obstacles to the provision of optimal end of life care in ICU

Contains fulltext : 172380.pdf (publisher's version ) (Open Access

Comparación de distintas estrategias para la predicción de muerte a corto plazo en el paciente anciano infectado

Objective. The aim of this study was to determine the utility of a post hoc lactate added to SIRS and qSOFA score to predict 30-day mortality in older non-severely dependent patients attended for infection in the Emergency Department (ED). Methods. We performed an analytical, observational, prospective cohort study including patients of 75 years of age or older, without severe functional dependence, attended for an infectious disease in 69 Spanish ED for 2-day three seasonal periods. Demographic, clinical and analytical data were collected. The primary outcome was 30-day mortality after the index event. Results. We included 739 patients with a mean age of 84.9 (SD 6.0) years; 375 (50.7%) were women. Ninety-one (12.3%) died within 30 days. The AUC was 0.637 (IC 95% 0.587-0.688; p= 2 and 0.698 (IC 95% 0.635- 0.761; p= 2. Comparing receiver operating characteristic (ROC) there was a better accuracy of qSOFA vs SIRS (p=0.041). Both scales improve the prognosis accuracy with lactate inclusion. The AUC was 0.705 (IC95% 0.652-0.758; p<0.001) for SIRS plus lactate and 0.755 (IC95% 0.696-0.814; p<0.001) for qSOFA plus lactate, showing a trend to statistical significance for the second strategy (p=0.0727). Charlson index not added prognosis accuracy to SIRS (p=0.2269) or qSOFA (p=0.2573). Conclusions. Lactate added to SIRS and qSOFA score improve the accuracy of SIRS and qSOFA to predict short-term mortality in older non-severely dependent patients attended for infection. There is not effect in adding Charlson index